|
WO9519952A1
|
|
Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure
|
|
AU1533495A
|
|
Phenyl ethanol amine ethers and uses thereof as beta-adreno-receptor agonists
|
|
WO9513812A1
|
|
Use of substituted 1,4-dihydropyridine to reduce intraocular pressure
|
|
WO9513811A1
|
|
Use of substituted thiazolidine derivatives in the treatment of raised intraocular pressure
|
|
HU9502623D0
|
|
Substituted alkyl-nitrates and their use to prepare pharmaceuticals for the treatment of pathologically increased intraocular pressure
|
|
AU5626494A
|
|
Nitroxy compounds with pharmaceutical properties
|
|
WO9408945A1
|
|
Substituted ethanolamine esters
|
|
DE4313726A1
|
|
Solid dosage form
|
